ResMed (RMD) Reports In-Line Q4 EPS
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $240.33 +1.94%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
CHA, EDXC, YAYO, More
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
CHA, EDXC, YAYO, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $2.08, in-line with the analyst estimate of $2.08. Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.22 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- Jiayin Group (JFIN) Reports Q2 Loss of RMB3.56
- IP Strategy Holdings receives Nasdaq noncompliance notice over late 10-Q
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
